Tony Nguyen
Tony Nguyen has made 32 investments in companies such as: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies, Orchestra BioMed, Encoded Therapeutics, Beta Bionics, ARMO BioSciences, Athira Pharma, immatics biotechnologies, Orchard Therapeutics, UNUM Therapeutics, Avidity Biosciences, Landos Biopharma, Pulmonx, Attune Pharmaceuticals, Nuance Biotech, Stoke Therapeutics, Ventyx Biosciences, Prometheus Biosciences, Tenaya Therapeutics, NiKang Therapeutics, Immunocore, Solid Biosciences, Milestone Pharmaceuticals, Biomea Fusion, Visus Therapeutics, Artiva Biotherapeutics, UroGen Pharma, ITeos Therapeutics, C4 Therapeutics, Pyxis Oncology.
Location of Tony Nguyen is United States.The free version of Angel Match provides limited data for Tony Nguyen. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.
Tony Nguyen is a Managing Director, Research Analyst and he his investment types are: Hedge Fund.
Tony Nguyen focuses investing in industries such as: Biotechnology, Health Care, Medical, Biopharma, Health Diagnostics, Life Science, Therapeutics, Genetics, Pharmaceutical, Clinical Trials.
A short brief about investor:
About
Investor type:
Locations:
Past investments
- AveXis
- Frequency Therapeutics
- Roivant Sciences
- Magnolia Medical Technologies
- Orchestra BioMed
- Encoded Therapeutics
- Beta Bionics
- ARMO BioSciences
- Athira Pharma
- immatics biotechnologies
- Orchard Therapeutics
- UNUM Therapeutics
- Avidity Biosciences
- Landos Biopharma
- Pulmonx
- Attune Pharmaceuticals
- Nuance Biotech
- Stoke Therapeutics
- Ventyx Biosciences
- Prometheus Biosciences
- Tenaya Therapeutics
- NiKang Therapeutics
- Immunocore
- Solid Biosciences
- Milestone Pharmaceuticals
- Biomea Fusion
- Visus Therapeutics
- Artiva Biotherapeutics
- UroGen Pharma
- ITeos Therapeutics
- C4 Therapeutics
- Pyxis Oncology